Capricor Therapeutics(GB:0HTB)
GB:0HTB
Capricor Therapeutics financials statements
Capricor Therapeutics (0HTB) Income Statement
0 Followers
Capricor Therapeutics Income Statement
Last quarter (Q2 2026), Capricor Therapeutics's total revenue was $0.00. In Q2, Capricor Therapeutics's net income was $-40.73M. See Capricor Therapeutics’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 0.00 | $ 22.27M | $ 25.18M | $ 2.55M | $ 244.90K | |
| $ 0.00 | $ -27.70M | $ -11.27M | $ -19.27M | $ 244.90K | |
| $ 108.14M | $ 14.87M | $ 12.81M | $ 10.43M | $ 21.18M | |
| Depreciation and Amortization | $ 1.89M | $ 1.43M | $ 1.07M | $ 533.13K | $ 245.70K |
| $ -100.11M | $ -39.04M | $ -21.22M | $ -28.49M | $ -19.78M | |
| $ -108.14M | $ -42.56M | $ -24.08M | $ -29.70M | $ -20.94M | |
| $ 3.10M | $ 2.10M | $ 1.79M | $ 677.85K | $ 915.92K | |
| $ -105.04M | $ -40.47M | $ -22.29M | $ -29.02M | $ -20.02M | |
| $ -105.04M | $ -40.47M | $ -22.29M | $ -29.02M | $ -20.02M | |
| Per Share Metrics | |||||
| Basic EPS | $ -2.26 | $ -1.15 | $ -0.83 | $ -1.18 | $ -0.87 |
| Diluted EPS | $ -2.26 | $ -1.15 | $ -0.83 | $ -1.18 | $ -0.87 |
| Weighted Average Shares Outstanding | 46.48M | 35.22M | 26.78M | 24.55M | 23.09M |
| Weighted Average Shares Outstanding (Diluted) | 46.48M | 35.22M | 26.78M | 24.55M | 23.09M |
Currency in USD
